What was the public and scientific perception of Down syndrome during the first half of the 20th century? How did the publication of an article in the Academy of Sciences by Jerome Lejeune, Marthe Gautier and Raymond Turpin on January 26, 1959, open the way to scientific and medical progress? Learn about the advancements made in medical care for people with Down syndrome since the discovery of trisomy 21, and the work of the Jerome Lejeune Foundation, in this video:
For over 20 years, the Jerome Lejeune Institute in France has provided specialized medical care for individuals with Down syndrome, continuing Dr. Jerome Lejeune’s legacy. Individuals with Down syndrome often present signs and symptoms differently and can experience challenges finding medical care customized to their needs.
The average medical costs for children with Down syndrome are twelve times higher than those without. They have an increased risk of health problems such as heart defects, hearing loss, obstructive sleep apnea, ear infections, eye diseases, Alzheimer’s disease, and more.
The Jerome Lejeune Foundation provides unparalleled medical care tailored exclusively for people with Down syndrome and their families. Its team of specialists are experienced in providing care to those with Down syndrome across medical fields, and includes geneticists, a neurologist, orthopedic surgeons, geriatricians, speech therapists, and dieticians.
Our goal is to expand our medical care and create the first holistic medical center for children and adults with Down syndrome in the United States, modeled after the center in France. The United States medical center will provide personalized care to meet patients’ specific needs.
We plan to open the medical center in 2020 – but we need your help.
Would you help us provide quality medical care for individuals with Down syndrome in the United States?